Skip to main content
OpenTrials

Clinical trial condition

Lymphohistiocytosis, Hemophagocytic

Explore clinical trials studying Lymphohistiocytosis, Hemophagocytic. Study availability and eligibility vary by location and protocol.

65 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Lymphohistiocytosis, Hemophagocytic trial results

Completed

A Post-authorization Study to Describe the Safety and Efficacy of Emapalumab for the Treatment of pHLH in Treatment Experienced Chinese Patients

NCT05744063

Conditions
Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Non-Langerhans-Cell, +3 more
Locations
  • Swedish Orphan Biovitrum Research site Shanghai, Fudan, China
  • Swedish Orphan Biovitrum Research site Beijing, Xicheng, China
  • Swedish Orphan Biovitrum Research site Beijing, China
  • Swedish Orphan Biovitrum Research site Chongqing, China
View Trial Details
Completed

Baby Detect : Genomic Newborn Screening

NCT05687474

Conditions
3-Hydroxy 3-Methyl Glutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency, +368 more
Locations
  • CRMN, Hôpital La Citadelle Liège, Wallonia, Belgium
View Trial Details
Completed

A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic Characteristics, and Immunogenicity of Plonmarlimab in Subjects With Rheumatic and Immunological Disease-associated Haemophagocytic Lymphohistiocytosis (HLH) (Also Known as Macrophage Activation Syndrome (MAS))

NCT07034209

Conditions
Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytoses, Histiocytosis, +3 more
Locations
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Renji Hospital of Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China
  • Beijing Peking Union Medical College Hospital Beijing, China
  • Beijing Peking University People's Hospital Beijing, China
View Trial Details
Completed

Study to Assess the Efficacy and Safety of Emapalumab in Primary Haemophagocytic Lymphohistiocytosis

NCT03312751

Conditions
Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Non-Langerhans-Cell, +3 more
Locations
  • Phoenix Children Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Alfred I. duPont Hospital for Children - Nemours Center for Cancer and Blood Disorders - Division of Pediatric Hematology Oncology Wilmington, Delaware, United States
View all 27 locations
View Trial Details

Related conditions